S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10

Sernova Stock Forecast, Price & News

+0.01 (+0.80 %)
(As of 10/22/2021 03:59 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume111,806 shs
Average Volume723,605 shs
Market CapitalizationC$328.34 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SVA News and Ratings via Email

Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter.

About Sernova

Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch System and associated technologies, including the cell pouch and systemic and/or locally immune protected therapeutic cells and tissues. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells or tissues for the treatment of chronic diseases, such as diabetes, hemophilia, and hypothyroid disease. The company has a research collaboration with AgeX Therapeutics, Inc. to generate immune-protected universal therapeutic cells. Sernova Corp. was incorporated in 1998 and is headquartered in London, Canada.


Sernova Corp. (SVA.V)
July 28, 2021 |  uk.finance.yahoo.com
Sernova Corp. Registered Shares (PSH.SG)
October 16, 2020 |  ca.finance.yahoo.com
October 13, 2020 |  au.finance.yahoo.com
Sernova Corp. (PSH.F)
August 17, 2020 |  ca.finance.yahoo.com
August 1, 2020 |  au.finance.yahoo.com
Investors Cheer Sernova Data
July 3, 2019 |  www.baystreet.ca
See More Headlines

Industry, Sector and Symbol

Diagnostics & Research
Year Founded

Sales & Book Value

Annual Sales
Cash Flow
C$0.12 per share
Book Value
C$0.12 per share





Market Cap
C$328.34 million
Next Earnings Date
2/7/2022 (Estimated)


Overall MarketRank

0.83 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Sernova (CVE:SVA) Frequently Asked Questions

What stocks does MarketBeat like better than Sernova?

Wall Street analysts have given Sernova a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sernova wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Sernova's next earnings date?

Sernova is scheduled to release its next quarterly earnings announcement on Monday, February 7th 2022.
View our earnings forecast for Sernova

How has Sernova's stock been impacted by COVID-19 (Coronavirus)?

Sernova's stock was trading at C$0.15 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SVA shares have increased by 769.0% and is now trading at C$1.26.
View which stocks have been most impacted by COVID-19

What other stocks do shareholders of Sernova own?

What is Sernova's stock symbol?

Sernova trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SVA."

How do I buy shares of Sernova?

Shares of SVA and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Sernova's stock price today?

One share of SVA stock can currently be purchased for approximately C$1.26.

How much money does Sernova make?

Sernova has a market capitalization of C$328.34 million.

How many employees does Sernova have?

Sernova employs 1,959 workers across the globe.

What is Sernova's official website?

The official website for Sernova is www.sernova.com.

Where are Sernova's headquarters?

How can I contact Sernova?

Sernova's mailing address is 700 Collip Cir Suite 114, LONDON, ON N6G 4X8, Canada. The company can be reached via phone at +1-519-8585184.

This page was last updated on 10/24/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.